With indications for both type 2 diabetes and weight loss, Novo Nordisk achieved a remarkable sales figure of DKK 100.222 billion (approximately USD 14.232 billion) in the first three quarters of 2023, marking an impressive year-on-year growth of 86% despite limited production capacity. Novo Nord...
FDA-Approved Weight Loss Drugs: Can They Help You? Should you mix muscle relaxants with alcohol? Side Effects of Weight Loss Drugs Statins for high cholesterol: Are the benefits worth the risk? Which Drugs Cause Weight Gain? Treatment options Medications for Atherosclerosis Medications for Heart Di...
Novo Nordisk ranked third on the list with a 51.5% growth rate, landing at $355 billion in market capitalization in 2023. Novo’s growth has been fueled by skyrocketing demand for its GLP-1 drugs—Wegovy and Ozempic. The company is expecting an even bigger 2024, projecting salesgrow...
Scientific Animations - The top medical animation studio for pharma and medical device marketing, training and interactive app development. We make you look good.
percent of US consumers considered prescription medication, including glucagon-like peptide-1 (GLP-1) drugs, to be a “very effective” intervention. Prescription medication is perceived differently elsewhere: less than 30 percent of UK and China consumers considered weight loss ...
October 6, 2024 Health Drugs like Ozempic and Wegovy are linked to a lower risk of Alzheimer’s disease, new study says BYAni Freedman October 24, 2024 Success Marc Benioff says that from now on CEOs will no longer lead all-human workforces—enter the new era of AI coworkers ...
this does not completely solve the problem. After all, PEP is still the eternal 2nd behind Coke in the beverage industry. Finally, the rise of weight loss drugs such as Ozempic is making the news and the market is concerned it will impact snacks and soft drink (along with other “unhealth...
A growing number of companies are testing muscle-building agents to counter the side effects of dramatic weight loss and potentially to preserve lean muscle into old age. Skeletal muscle takes a hit during weight loss. To reduce the impact on muscle mass, biotechs are pairing obesity drugs with...
For a top drugmaker like Eli Lilly (NYSE: LLY), developing new drugs is key to ensuring that its business continues to grow. Patents don't last forever, so continuing to innovate is the only surefire way to be successful and remain a top company in the h
size-fits-all situation. I'm going to reach for certain drugs for certain patients. The great thing about DPP-4 inhibitors like Januvia is that it's very well-tolerated, it's very simple to take, it's a daily-medication, it's weight neutral, and so it's got a very favorable ...